We are live on ! Find out more
OAC

OMERS Administration Corp Portfolio holdings

AUM $16.7B
1-Year Est. Return 35.96%
This Fund
S&P 500
This Quarter Est. Return
+23.08%
1 Year Est. Return
+35.96%
3 Year Est. Return
+106.41%
5 Year Est. Return
+114.67%
10 Year Est. Return
+344.51%
AUM
$16.7B
AUM Growth
+$1.16B
Cap. Flow
-$545M
Cap. Flow %
-3.26%
Top 10 Hldgs %
30.99%
Holding
1,188
New
92
Increased
466
Reduced
166
Closed
282

Top Sells

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$463M
2
AAPL icon
Apple
AAPL
+$266M
3
PLD icon
Prologis
PLD
+$192M
4
NVDA icon
NVIDIA
NVDA
+$168M
5
KO icon
Coca-Cola
KO
+$164M

Sector Composition

Rank Sector Weight
1 Technology 25.31%
2 Financials 22.79%
3 Industrials 9.5%
4 Communication Services 8.24%
5 Consumer Discretionary 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCEL icon
1001
FuelCell Energy
FCEL
$1.22B
-17,700
Closed -$116K
FWDI
1002
Forward Industries Inc
FWDI
$462M
-38,900
Closed -$172K
FOSL icon
1003
Fossil Group
FOSL
$306M
-49,700
Closed -$214K
FROG icon
1004
JFrog
FROG
$10.3B
-6,600
Closed -$310K
GALT icon
1005
Galectin Therapeutics
GALT
$435M
-24,100
Closed -$67.2K
GEOS icon
1006
Geospace Technologies
GEOS
$69.2M
-11,100
Closed -$135K
GFL icon
1007
GFL Environmental
GFL
$18.8B
-20,400
Closed -$851K
GL icon
1008
Globe Life
GL
$13.2B
-2,799
Closed -$390K
GLDD
1009
DELISTED
Great Lakes Dredge & Dock
GLDD
-864,000
Closed -$14.7M
GLUE icon
1010
Monte Rosa Therapeutics
GLUE
$1.16B
-27,100
Closed -$446K
CBIO
1011
Crescent Biopharma
CBIO
$764M
-17,800
Closed -$327K
GNLX icon
1012
Genelux
GNLX
$113M
-17,600
Closed -$42.6K
GPRO icon
1013
GoPro
GPRO
$312M
-265,800
Closed -$205K
GSIT icon
1014
GSI Technology
GSIT
$214M
-17,000
Closed -$87.4K
HII icon
1015
Huntington Ingalls Industries
HII
$11.3B
-1,656
Closed -$629K
HIMS icon
1016
Hims & Hers Health
HIMS
$6.52B
-19,200
Closed -$399K
HOLX
1017
DELISTED
Hologic
HOLX
-10,829
Closed -$819K
HRL icon
1018
Hormel Foods
HRL
$11.8B
-13,748
Closed -$311K
HSIC icon
1019
Henry Schein
HSIC
$9.94B
-4,634
Closed -$342K
HUBS icon
1020
HubSpot
HUBS
$12.3B
-29,401
Closed -$7.18M
AGIG
1021
Abundia Global Impact Group
AGIG
$53M
-24,500
Closed -$35.3K
IMMX icon
1022
Immix Biopharma
IMMX
$944M
-20,400
Closed -$186K
IMRX icon
1023
Immuneering
IMRX
$307M
-22,400
Closed -$118K
IMUX icon
1024
Immunic
IMUX
$173M
-16,830
Closed -$187K
INFU icon
1025
InfuSystem Holdings
INFU
$241M
-12,900
Closed -$119K

Similar funds

OMERS Administration Corp's Q2 2026 Portfolio in Review

As of Q2 2026, OMERS Administration Corp held 1,188 positions worth $16.7B, up 7.5% from $15.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

OMERS Administration Corp withdrew a net $545M in Q2 2026, closing 282 positions and reducing 166 holdings. Its most notable exit was AstraZeneca, an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

Against the trend, OMERS Administration Corp opened a new position in Brookfield Asset Management worth $30.3M.

  • OMERS Administration Corp's largest Q2 2026 buy was Brookfield Asset Management: 675,600 shares worth $30.3M.
  • OMERS Administration Corp added most to Canadian Natural Resources in Q2 2026, an estimated $318M increase.
  • OMERS Administration Corp's biggest Q2 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $463M.
  • OMERS Administration Corp fully exited AstraZeneca in Q2 2026, selling an estimated $160M.
  • OMERS Administration Corp's ten largest holdings make up 31% of its $16.7B portfolio in Q2 2026.
  • OMERS Administration Corp opened 92 new positions and closed 282 in Q2 2026.
  • OMERS Administration Corp's portfolio value rose 7.5% quarter-over-quarter to $16.7B.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.